Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In order to evaluate the efficacy and safety of recombinant human follicle stimulating hormone (r-hFSH) in combination with urinary human chorionic gonadotrophin (HCG) to induce spermatogenesis and fertility in gonadotrophin-deficient men, we conducted a prospective, open, non-comparative multicentre study in two Australian academic medical centres. Ten men with gonadotrophin deficiency requiring induction of spermatogenesis and fertility were treated with HCG for 3-6 months followed by the s.c. self-administration of injections of r-hFSH in combination with HCG for 18 months. Among the eight men who commenced r-hFSH treatment, seven demonstrated sperm output at a median of 6 months and five achieved the target sperm output of 1. 5x10(6) per ml at a median of 9 months of FSH treatment. Mean testicular volume increased by 4.2 ml during FSH treatment. Three men produced pregnancies in their partners, two of which resulted in the birth of healthy babies and a third patient's partner had a miscarriage. We conclude that r-hFSH is well tolerated and effective in inducing testis growth, spermatogenesis and fertility in gonadotrophin-deficient men. The efficacy of r-hFSH seems comparable with urinary FSH at restoring normal fertility in gonadotrophin-deficient men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of Spermatogenesis by Gonadotropins in Men with Hypogonadotropic Hypogonadism
Finkel, D. M., Phillips, J. L., & Snyder, P. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509123131102 · Cited by 240
BURRIS, A. S., RODBARD, H. W., WINTERS, S. J., & SHERINS, R. J. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1144 · Cited by 185 · cited 1×
“Clinical studies suggest that prolonged HCG administration may initiate (De Sanctis et al., 1988; Vicari et al., 1992), maintain (Johnsen, 1978; Burger and Baker, 1984) or reinitiate (Matsumoto et al., 1986) spermatogenesis in some gonadotrophin-deficient men.”
BackgroundVICARI, E., MONGIOÌ, A., CALOGERO, A. E., MONCADA, M. L., SIDOTI, G., POLOSA, P., & D'AGATA, R. (1992) · International Journal of Andrology · doi:10.1111/j.1365-2605.1992.tb01131.x · Cited by 145 · cited 2×
“Clinical studies suggest that prolonged HCG administration may initiate (De Sanctis et al., 1988; Vicari et al., 1992), maintain (Johnsen, 1978; Burger and Baker, 1984) or reinitiate (Matsumoto et al., 1986) spermatogenesis in some gonadotrophin-deficient men.”
Background
Cited by
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
“However, sperm numbers when partners of these patients conceive are far below the “normal range” (70, 71).”
Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0345 · Cited by 1,026
Minhas, S., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.08.014 · Cited by 622
Clinical Management of Congenital Hypogonadotropic Hypogonadism
Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., Raivio, T., & Pitteloud, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00116 · Cited by 396
Liu, P. Y., Baker, H. W. G., Jayadev, V., Zacharin, M., Conway, A. J., & Handelsman, D. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1648 · Cited by 253
Self-citation
Metadata
- Authors
- Liu, P. Y., Turner, L., Rushford, D., McDonald, J., Baker, H. W. G., Conway, A. J., & Handelsman, D. J.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06
- Volume
- 14
- Issue
- 6
- Pages
- 1540-1545
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W1982379911
- Cited by
- 139
- References
- 3
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. https://app.cochat.ai/papers/10.1093/humrep/14.6.1540
- The paper
- Liu, P. Y., Turner, L., Rushford, D., McDonald, J., Baker, H. W. G., Conway, A. J., & Handelsman, D. J. (1999). Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Human Reproduction. https://doi.org/10.1093/humrep/14.6.1540
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.